Role of diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) in differentiating between benign and malignant breast lesions  by Abdulghaffar, Wael & Tag-Aldeen, Magdy M.
The Egyptian Journal of Radiology and Nuclear Medicine (2013) 44, 945–951
OEgyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comORIGINAL ARTICLERole of diﬀusion-weighted imaging (DWI)
and apparent diﬀusion coeﬃcient (ADC)
in diﬀerentiating between benign and malignant
breast lesions* Corresponding author.
E-mail addresses: ewaeil@yahoo.com, ahmharon@yahoo.com
(W. Abdulghaffar).
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
Production and hosting by Elsevier
0378-603X  2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2013.09.009pen access under CC BY-NC-ND license.Wael Abdulghaﬀar a,*, Magdy M. Tag-Aldeen ba Medical Imaging Department, Mansoura University, Egypt
b General Surgery Department, Al Noor Specialist Hospital, Holy Makah, Saudi ArabiaReceived 18 August 2013; accepted 14 September 2013
Available online 9 October 2013KEYWORDS
Diffusion-weighted imaging;
Apparent diffusion
coefﬁcient;
MRI breastAbstract Objective: To assess the role of DWI and ADC in differentiating between benign and
malignant breast lesions.
Materials and methods: 51 patients (age range 24–66 years; mean age 48 years) were included in
our study. MRI was done using bilateral fat-suppressed T2- weighted fast spin-echo, STIR, axial
T1-weighted fast spin-echo. DWI series were acquired using echo planar imaging pulse sequences
incorporated with diffusion gradients and ﬁnally dynamic contrast enhancement study was done.
Results: Sixty three lesions were detected in 51 patients included in our study. Twenty one lesions
were malignant, three lesions were intermediate and twenty two lesions were ﬁbroadenoma accord-
ing to the ﬁnal histopathological study and seventeen lesions were breast cysts. A total of 21 lesions
showed lower ADC values than benign lesions and were in the range of 0.76–1.29 · 103 mm2/s and
were diagnosed as malignant breast lesions. The sensitivity and speciﬁcity for DWI in the differen-
tiating malignant from benign breast lesions were calculated and showed 95.4% and 97.5%, respec-
tively.
Conclusion: DWI is easy to obtain in short scan time and easy to evaluate, and ADC values can
differentiate between benign and malignant breast lesions with high sensitivity and speciﬁcity.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Diffusion is the result of thermal ﬂuctuations with a random
pattern and this is often referred to as ‘‘Brownian motion’’.
Diffusion-weighted imaging (DWI) is the primary modality
that is used to evaluate acute cerebral infarction (1). DWI
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the ovaries, pancreas, prostate, liver and breast. Until now,
there have been few reports published about using the DWI
technique to detect and characterize breast tumors, and espe-
cially malignant breast tumor (2–3).
Early reports on breast lesion interpretation by MRI relied
entirely on lesion enhancement kinetics or lesion morphology
(4). But neither enhancement kinetics nor lesion morphology
alone was sufﬁcient for differential diagnosis and resulted in
a poor speciﬁcity. Over the past decade, new MR techniques
and interpretation strategies have been developed to increase
the speciﬁcity and positive predictive value (PPV) of breast
MRI. The most proposed strategy includes obtaining MR
images of both high spatial and temporal resolution and ana-
lyzing the morphologic and the kinetic features in combina-
tion. In recent publications using this new interpretation
technique, increased speciﬁcities are reported, ranging between
67% and 92% (4–5).
Use of diffusion-weighted (DW) imaging is another ap-
proach that may improve MR imaging lesion characterization.
DW imaging has the potential to yield physiologic information
about the functional environment and movement of water in
normal versus abnormal tissue. DW imaging is sensitive to
changes in the micro-diffusion of water in the intracellular
and extracellular spaces (6–7). Differences in the apparent
diffusion coefﬁcients (ADCs) of benign and malignant breast
lesions have been reported (8). The ADCs of malignant breast
lesions are usually lower than those of benign lesions, indicat-
ing restricted water diffusion and increased cellularity. The
ADCs of benign lesions are higher, reﬂecting normal cellular-
ity and no restriction of water movement (9–10).
Diffusion-weighted imaging (DWI) was recently integrated
into the standard breast MRI examination for this purpose
(11–19). It is a noninvasive technique that measures the ran-
dom motion of free water protons and characterizes the tissues
with a mechanism that is different from T1 and T2 relaxation.
The motion of water protons in the tissue is affected by ﬂuid
viscosity, membrane permeability, blood ﬂow, and cellularity
of the tissue. For the quantiﬁcation of this motion, apparent
diffusion characteristic (ADC) values are used. Since 2002,
many studies (11–18) have revealed the usefulness of DWI in
differentiation of malignant from benign tumors of the breast.
In these studies, sensitivity in the range of 80–96% and
speciﬁcity in the range of 46–91% were reported. Recently
Yabuuchi et al. (18) revealed 92% sensitivity and 86% speciﬁc-
ity and Partridge et al. (20) revealed 10% improvement in the
PPV with the addition of DWI to dynamic contrast-enhanced
MRI (DCE-MRI) in the characterization of breast masses.
2. Objective
The aim of our study was to shed light on the role of diffusion-
weighted imaging (DWI) and the apparent diffusion coefﬁcient
(ADC) for the assessment of breast lesions.
3. Materials and methods
3.1. Patients
Between February 2011 and February 2013, 51 patients (age
range, 24–66 years; mean age, 48 years) with suspicious clinicalﬁndings and positive diagnoses at mammography were
included in our study. Patients were imaged using conventional
MRI, DWI and DCE-MRI before biopsy of their breast tu-
mors. Approval for the study was obtained from the local eth-
ics committee in the Alnoor specialist hospital, in Holey
Makkah. Written informed consent was obtained from all pa-
tients before MRI. In all patients, MRI was performed
bilaterally.
3.2. MRI technique
MRI examinations were performed before biopsy (in solid
breast lesions) and within the 2 weeks before surgery. Patients
were examined in the prone position using a 1.5-T MRI scan-
ner (Magnetom Espree, Siemens Healthcare) with a dedicated
4-channel phased array bilateral breast coil. Before administra-
tion of contrast media, axial bilateral fat-suppressed T2-
weighted fast spin-echo, axial STIR, axial T1-weighted fast
spin-echo and DWI series were acquired.
DW image was performed in axial slice orientation using
echo planar imaging pulse sequences incorporating with diffu-
sion gradients. DW EPI with fat suppression was applied using
TR/TE of about 8400/98 ms, FOV of 340 · 170 mm, matrix:
192 · 96 and a slice thickness of 4 mm. Spectral pre-saturation
with inversion recovery (SPAIR) was used for fat suppression.
An acceleration factor of two was applied using the general-
ized auto-calibrating partially parallel acquisition (GRAPPA)
of parallel imaging technique. Motion-probing gradients in
three orthogonal orientations were applied with b values of
50, 400 and 800 using 3-scan trace calculation. Isotropic diffu-
sion-weighted (trace) images were reconstructed for each b va-
lue. For quantitative analysis of the data acquired from DWI,
ADC maps were automatically created using software pro-
vided by the MRI system manufacturer (Syngo, Siemens
Healthcare) using three b values (50, 400, and 800 s/mm2).
We apply the DW sequences prior to the dynamic scan as
the T1 relaxation due to the contrast agent will cause changes
to the inversion of the tissue and thus can have a strong
impact.
Finally, dynamic axial bilateral breast images of fat-sup-
pressed high-resolution T1-weighted 3D fast gradient-echo
images were sequentially acquired. Five measurements were
acquired one before and four after the administration of
contrast media. For the dynamic study, gadopentetate
dimeglumine (Magnevist) was administered IV using a
power injection at a dose of 0.1 mmol/kg of body weight
at a ﬂow rate of 2 mL/s, followed by ﬂushing with 25 mL
of saline. The parameters were as follows: TR/TE 4.2/1.6;
ﬂip angle 15; FOV 340 · 340 mm; matrix 512 · 410; thick-
ness 0.9 mm; acquisitions 1; and acquisition time 110 s.
SPAIR for fat suppression and a GRAPPA acceleration fac-
tor of two for parallel imaging technique were also applied.
DCE was done in 50 cases and contraindicated in one pa-
tient with renal failure on hemodialysis with GFR less than
30 Ml/min.
4. Results
Sixty three lesions were detected in the 51 patients included in
our study. Twenty one lesions were malignant, three lesions
were intermediate and twenty two lesions were ﬁbroadenoma
Table 1 Different ADC values for malignant, intermediate, and benign breast lesions.
Types of lesions No. of lesions N= 63 ADC values (·103 mm2/s)
Range of ADC Mean ADC
Malignant breast lesions 21 0.76–1.29 0.93 ± 0.27
Intermediate lesions (Phylloides) 3 1.15–1.45 1.25 ± 0.15
Fibroadenomas 22 1.23–1.67 1.48 ± 0.33
Breast cysts 17 1.75–2.56 1.89 ± 0.31
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sions were breast cysts.
According to the ADC values (Table 1) thirty nine lesions
were benign with 17 lesions were cysts (Fig. 1), and showed
mean ADC values of 1.89 ± 0.31 · 103 mm2/s and ADC
range of (1.75–2.56 · 103 mm2/s) and twenty two lesions were
ﬁbroadenomas (Fig. 2) and showed mean ADC values of
1.48 ± 0.33 · 103 mm2/s and ADC range of 1.23–
1.67 · 103 mm2/s.
In our study three lesions were intermediate (phylloides) le-
sions (Fig. 3) and showed mean ADC values of
1.25 ± 0.15 · 103 mm2/s and ADC range of 1.15–1.45 · 10
3 mm2/s and twenty one lesions were malignant lesions (Figs.
4 and 5) and showed mean ADC values of 0.93 ± 0.27 · 10
3 mm2/s and ADC range of 0.76–1.29 · 103 mm2/s (See
Fig. 6).
A total of 21 lesions showed lower ADC values than benign
lesions and were in the range of 0.76–1.29 · 103 mm2/s and
were diagnosed as malignant breast lesions.
In our study, using a cutoff point 1.25 · 103 mm2/s, the
sensitivity, and speciﬁcity for DWI in the differentiating malig-
nant breast lesions from benign breast lesions obtained wereFigure 1 A 46-year-old woman with small right breast ﬁbroaden
homogeneously enhancing right breast mass (white arrow). (B) STIR im
weighted image shows small slightly high-signal intensity mass. (D) AD
was 1.45 · 103 mm2/s.95.4% and 97.5%, respectively and total accuracy of about
96.7%.
5. Discussion
Breast MRI is the widely accepted diagnostic approach for
evaluating the breast. To improve the sensitivity of detecting
breast cancer, several diverse techniques are used for breast
MRI (21). In particular, dynamic-enhanced MRI provides for
evaluating multiple foci of carcinoma in the breast and it dis-
plays extremely high sensitivity for identifying breast cancer.
However, dynamic-enhanced breast MRI has some disadvan-
tages such as being time-consuming and costly, the possible side
effects of the contrast media and the relatively low speciﬁcity
compared to mammography and ultrasonography (22–24).
Generally in biological tissues, microscopic motion in-
cludes both the molecular diffusion of water and the blood
microcirculation in the capillary network, and both diffusion
and perfusion affect the ADC values. Because of the extent
of micro-vessels in malignant breast tumor, the ADC value
can be strongly affected by perfusion when the b value is
small. A previous report insisted that b-values less thanoma. (A) Axial post-contrast T1-weighted image shows small
age shows small high signal intensity mass. (C) The axial diffusion
C: the apparent diffusion coefﬁcient value of the right breast tumor
Figure 2 A 43-year-old woman with left breast cyst. (A) Axial post-contrast T1-weighted image shows non enhancing left breast lesion
(white arrow). (B) STIR image displays high signal intensity of the mass. (C) The axial diffusion weighted image shows high-signal
intensity mass (Which may be due to shine through effect). (D) ADC: the apparent diffusion coefﬁcient value of the left breast cyst was
1.96 · 103 mm2/s.
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(21). However, we used EPI with a b-value up to 800 s/
mm2 so we could obtain diffusion effects without any signif-
icant image distortion.
Benign breast tumor including breast cyst and ﬁbroade-
noma demonstrate high signal intensity on T2-weighted MR
images; however, the signal intensity of benign tumors is vari-Figure 3 A 47 year-old woman with large left breast phylloides tumo
enhancing left breast mass (white arrow) and lobulated parts (white arr
The axial diffusion weighted image shows mixed signal intensity mass.
tumor was 1.35 · 103 mm2/s.able on diffusion-weighted images and may be inﬂuenced by b
value much more than the signal intensity of malignant tumors
because of T2 shine-through. These benign tumors may dis-
play high signal intensity on diffusion-weighted images ob-
tained at lower b values; on diffusion-weighted images
obtained at higher b values, these tumors become isointense
and may not be identiﬁed (17,18).r. (A) The axial post-contrast T1-weighted image shows markedly
ow heads). (B) STIR image shows mixed signal intensity mass. (C)
(D) ADC: the apparent diffusion coefﬁcient value of the left breast
Figure 4 A 51 year-old woman with right breast ductal carcinoma. (A) Axial post-contrast T1-weighted image shows markedly
enhancing right breast mass (white arrow). (B) STIR image shows high signal intensity mass with speculation. (C) The axial diffusion
weighted image shows high-signal intensity mass with speculation. (D) ADC: the apparent diffusion coefﬁcient value of the right breast
tumor was 0.83 · 103 mm2/s.
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on DWI. The signal intensity of cysts remains high at b values
of 800 s/mm2 or lower, which were used in our breast MR
imaging. A simple cyst shows greatly reduced signal intensity
on an image obtained at a b value of 1500 s/mm2 comparedFigure 5 A 63 year-old woman with left breast invasive ductal ca
markedly enhancing left breast mass with speculation (white arrow). (
(C) The axial diffusion weighted image shows high-signal intensity m
value of the left breast tumor was 1.15 · 103 mm2/s.with an image obtained at a b value of 1000 s/mm2 with the
same window setting. However, a cyst with condensed or pro-
teinaceous content sometimes has a high signal intensity, even
at higher b values (25–27).rcinoma. (A) The axial post-contrast T1-weighted image shows
B) STIR image shows high signal intensity mass with speculation.
ass with speculation. (D) ADC: the apparent diffusion coefﬁcient
Figure 6 Box plots graphs of apparent diffusion coefﬁcient
(ADC) values for malignant (n= 21) and benign (42) lesions in
our study.
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mors is that ﬁne-needle aspiration cytology, or mammography,
or US can not be used to differentiate ﬁbroadenomas from
phyllodes tumors. Fine-needle aspiration cytology may lead
to the misdiagnosis of a benign phyllodes tumor as a ﬁbroad-
enoma. According to previous study results, either a hypoin-
tense area on T2-weighted images or a low ADC area on
diffusion-weighted images is suggestive of an interstitial hyper-
cellular lesion. Therefore, MR imaging can be used to guide
the selection of an appropriate biopsy site (28). In our study
there is limitation in phylloides the assessment because diffu-
sion-weighted MR imaging was performed in only 3 patients;
therefore, the correlation between ADC and histologic grade
may be weak.
Malignant breast masses usually have higher cellularity, the
majority of invasive ductal carcinomas demonstrate higher sig-
nal intensity and lower ADC values than do benign tumors
and normal breast parenchyma on diffusion-weighted images.
In addition, there is occasionally central hypointensity in
IDCs, which is thought to represent necrosis or ﬁbrosis. This
appearance usually corresponds to the appearance on con-
trast-enhanced T1-weighted MR images. High-resolution dif-
fusion-weighted imaging can display the morphologic
features of the tumor, which may be helpful for interpretation
(9,17,25,26). In our study, while calculating ADC values, we
avoid including the central necrosis of the tumor, otherwise,
the resulting ADC value will not be accurate and will not reli-
ably reﬂect the physiologic environment of the tumor.
In our study the mean ADC value for benign breast lesions
was 1.48 ± 0.33 · 103 mm2/s and ADC range was 1.23–
1.67 · 103 mm2/s and for malignant breast lesions, mean
ADC value was 0.93 ± 0.27 · 103 mm2/s and ADC range
was 0.76–1.29 · 103 mm2/s.
These values agreed with the previous studies (21,27,29–31)
regarding the mean ADC values in differentiating benign from
malignant breast lesions.
In our study, the sensitivity, and speciﬁcity for DWI in the
differentiating malignant breast lesions from benign breast le-
sions were 95.4% and 97.5%, respectively. The sensitivity and
speciﬁcity of diffusion WI in differentiating benign and malig-nant breast lesion in our study is in agreement of previous
studies (15,19,32) which showed the sensitivity and speciﬁcity
of DWI in the differentiation between benign and malignant
breast lesions were ranging from 81% to 97%, and from
80% to 100%, respectively.
6. Conclusion
In conclusion, DWI is easy to obtain in short scan time and
easy to evaluate, and ADC values can differentiate between be-
nign and malignant breast lesions with high sensitivity and
speciﬁcity. DWI is problem solving sequence in patients with
contraindication to contrast media. We add DWI sequence
to the standard MRI examination of the breast before contrast
study and according to the result of our study it is a promising
sequence. However, more studies with larger populations are
needed for more evaluation of DWI in breast lesions.
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